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Local translation of mRNAs is a mechanism by which cells can rapidly remodel synaptic
structure and function. There is ample evidence for a role of synaptic translation in the
neuroadaptations resulting from chronic drug use and abuse. Persistent and coordinated
changes of many mRNAs, globally and locally, may have a causal role in complex disorders
such as addiction. In this review we examine the evidence that translational regulation by
microRNAs drives synaptic remodeling and mRNA expression, which may regulate the
transition from recreational to compulsive drug use. microRNAs are small, non-coding
RNAs that control the translation of mRNAs in the cell and within spatially restricted sites
such as the synapse. microRNAs typically repress the translation of mRNAs into protein
by binding to the 3′UTR of their targets. As ‘master regulators’ of many mRNAs, changes
in microRNAs could account for the systemic alterations in mRNA and protein expression
observed with drug abuse and dependence. Recent studies indicate that manipulation of
microRNAs affects addiction-related behaviors such as the rewarding properties of cocaine,
cocaine-seeking behavior, and self-administration rates of alcohol.There is limited evidence,
however, regarding how synaptic microRNAs control local mRNA translation during chronic
drug exposure and how this contributes to the development of dependence. Here, we
discuss research supporting microRNA regulation of local mRNA translation and how drugs
of abuse may target this process. The ability of synaptic microRNAs to rapidly regulate
mRNAs provides a discrete, localized system that could potentially be used as diagnostic
and treatment tools for alcohol and other addiction disorders.
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INTRODUCTION, BACKGROUND, AND RATIONALE
Chronic drug abuse induces long-term changes in brain gene and
protein expression, which likely contribute to the neuropatholo-
gies associated with abuse and dependence (Nestler, 2001; Kauer
and Malenka, 2007). Drug-induced transcriptional reprogram-
ming in the brain may account for some of the effects of repeated
drug exposure (Mayﬁeld et al., 2008; Robison and Nestler, 2011;
Ron and Messing, 2013). Ultimately, neuroadaptations due to
chronic drug use are controlled by the regulation of many genes
expressedwithin individual neurons or glial cells (Farris andMiles,
2012). At the cellular level, changes in molecular pathways origi-
nate from changes in gene expression and translation of proteins.
Re-organization of synaptic structure and function is one mani-
festation of these changes. Many of the functional pathways that
are altered in addiction paradigms include growth factors (Ron
and Messing, 2013), serine-threonine kinases (Sanna et al., 2002;
Lesscher et al., 2009), glutathione pathway enzymes, protein trans-
lation (Neasta et al., 2010; Barak et al., 2013), and inﬂammatory
pathways (Blednov et al., 2011; Gorini et al., 2014).
Proteins can be directly translated in synaptic regions, allow-
ing cells to rapidly respond to stimuli and bypassing the need
to transport proteins to the synapse, an energetically costly and
slow process. Translation is an important mechanism underly-
ing synaptic plasticity and is controlled locally in response to
environmental signals (Ule and Darnell, 2006; Schratt, 2009).
Synaptic translation is one way by which drugs of abuse induce
targeted neuroadaptations (Nunez and Mayﬁeld, 2012). Whole
cell preparations represent a crude system for studying synaptic
structure and function, and synaptoneurosome (SN) preparations
may be better suited for localized studies (Most et al., 2014). Drug-
induced neuroadaptations and transcriptional changes inﬂuence
a complex regulatory network that controls how and when the
synaptic mRNAs are translated (Smalheiser, 2008; Smalheiser and
Lugli, 2009). microRNAs, in part, regulate local protein synthesis
and the molecules that control it. Many of the characteristic alter-
ations in synaptic composition due to chronic drug exposure may
arise from alterations in microRNAs (Eipper-Mains et al., 2011).
This review examines how microRNAs regulate synaptic transla-
tion and how this relates to the molecular pathways in drug use
disorders.
LOCAL TRANSLATION AT THE SYNAPSE
Synaptic translation occurs in response to neural activity follow-
ing chemical changes in the extracellular milieu. The ﬁrst evidence
came from electron micrographs showing clusters of polyribo-
somes at the synapse (Steward and Levy, 1982). Twenty years
later, the ﬁrst dynamic visualization of localized protein syn-
thesis was demonstrated when Aakalu et al. (2001) deﬁnitively
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showed translation within isolated dendrites in response to
brain-derived neurotrophic factor (BDNF). In addition, appli-
cation of dopamine to cells induced local protein translation
(Smith et al., 2005). Discrete increases in protein can occur in
as little as 5 min, as shown for activity-regulated cytoskeleton-
associated protein (Arc; Niere et al., 2012), or in 20 min for
Ca2+/calmodulin-dependent protein kinase II (CaMKII; Gong
et al., 2006).
Location- and time-speciﬁc translation at an activated synapse
allows for spatially restricted expression of new proteins (Wang
et al., 2010). This specialized control works to ﬁne-tune trans-
lational mechanisms (Jung et al., 2014). Newly translated pro-
teins have fewer post-translational modiﬁcations, and thus will
have different signaling properties than older proteins (Jung
et al., 2014). All of these factors help ensure the rapid and
targeted responses required for neuronal signaling, and pertur-
bations to this balanced system can profoundly alter cellular
pathways.
THE 3′UTR (UNTRANSLATED REGION) IS NECESSARY FOR
mRNA TARGETING AND REGULATION AT THE SYNAPSE
Some of the ﬁrst evidence of synaptic translation came from the
SN preparation that enriches for pre-and post-synaptic compart-
ments of neurons, astrocytes, oligodendrocytes, and microglia
(Hollingsworth et al., 1985). This preparation can be used to
study the synaptic transcriptome (Hollingsworth et al., 1985;
Quinlan et al., 1999; Raab-Graham et al., 2006; Sosanya et al.,
2013) and synaptic translation of mRNAs (Raab-Graham et al.,
2006; Sosanya et al., 2013). The development of this preparation,
advances in microscopy and molecular cloning have facilitated
the discovery of the regulatory processes that govern mRNA
translation at the synapse.
SNs and post-synaptic enriched preparations helped identify
the method by whichmRNA is distributed into synaptic compart-
ments. The targeting of mRNA to dendrites occurs through the
3′UTR (Kislauskis and Singer, 1992; Mayford et al., 1996; Aakalu
et al., 2001; Miller et al., 2002; Martin and Ephrussi, 2009). The
3′UTR contains targeting elements that direct where and how
mRNA is translated. Evidence suggests that the targeting of mRNA
to the dendrite relies on cis-acting elements, often called zip
codes (Meer et al., 2012). Cis-acting elements are recognized by
trans-acting factors for proper dendritic targeting and regulation.
For example, localization of the beta-actin protein requires a 54-
nucleotide cis-acting zip code in the 3′UTR to target it to dendrites
and growth cones (Kislauskis and Singer, 1992; Zhang et al., 1999;
Eom et al., 2003).
The zip codes can be single- or double-stranded stem loop
structures comprised of multiple independent cis-acting elements
that aggregate and confer distinct localization properties for each
mRNA (Jambhekar and Derisi, 2007; Holt and Bullock, 2009).
Cis-acting elements are normally within the 3′UTR but have also
been found in the coding region and the 5′UTR. Regulation of
local translation occurs through extensive interactions between
the 3′UTR zip codes of mRNAs and microRNAs in concert with
RNA-binding proteins. Drug-induced alterations in microRNAs
may affect mRNA translation and distribution in the synapse via
these mechanisms.
ALCOHOL AND LOCAL TRANSLATION
The SN preparation has been used as a model for studying the
synaptic transcriptome. In order to measure discrete changes
within the synaptic transcriptome in response to chronic alco-
hol consumption, microarrays were used to proﬁle mRNAs from
paired SN versus total homogenate (TH) samples from mouse
amygdala (Most et al., 2014). The SN transcriptomes were dis-
tinct from the TH. The transcriptomes were then compared
in alcohol-treated and control mice using paired SN and TH
samples from the same subject. In SN 1,531 alcohol-responsive
mRNAs were identiﬁed compared to 462 in TH. Twenty three
percent of the TH alcohol-responsive mRNAs were also detected
in SN, compared to only 7% of SN alcohol-responsive mRNAs
that were detected in TH. The SN alcohol-responsive mRNAs
were highly enriched for neuronal processes (Cajigas et al., 2012)
and contained QTLs related to alcohol consumption in mice
(Mulligan et al., 2006).
RNA transcriptional, translational, spliceosomal and editing
machineries, as well as many ribosomal proteins, were over-
represented in the SN alcohol-responsive mRNAs (Most et al.,
2014). These changes were not observed in the TH preparation.
The RNAprocessingmachinery was also a highly over-represented
biological pathway associated with alcohol-responsive mRNAs,
further suggesting that chronic alcohol affects translational mech-
anisms in the synapse, which could alter gene expression. The
up-regulated alcohol-responsive mRNAs in SN were enriched
with GABA neurons, microglia, and astrocytes, while the down-
regulated mRNAs were enriched in neurons but not speciﬁcally
GABA or glutamate neurons. Expression changes in SN from
mouse amygdala corroborate those seen in the amygdala of
human alcoholics and include overlapping changes in GABA, glu-
tamate, and neuroimmune pathways. This suggests that SNs are
a useful model for characterizing discrete transcriptome changes
in chronic alcohol-treated animals, and the molecular changes
observed in SNs may overlap with changes observed in human
alcoholics.
ALCOHOL AND mTOR
Themammalian target of rapamycin (mTOR) is a serine/threonine
kinase necessary for protein synthesis in synapses and for activa-
tion of the translational machinery (Laplante and Sabatini, 2012).
By acting as a rapid and localized source of new proteins, this
pathway gives the cell an advantage over somatic translation and
subsequent protein trafﬁcking to the synapse. mTOR regulates
neuronal activity by maintaining system homeostasis mediated
by memory-induced synaptic adaptations (Shepherd et al., 2006;
Penney et al., 2012).
Sensory properties of alcohol (odor and taste) trigger alcohol-
related memories, and presentation of these alcohol cues causes
higher levels of relapse (Barak et al., 2013). The mTOR complex
1 (mTORC1) pathway and its downstream substrates are impor-
tant in alcohol-related memory reconsolidation. Alcohol alters
mTORC1 signaling in select amygdala and cortical regions of the
rat brain, resulting in increased levels of several synaptic proteins
(Barak et al., 2013). Disruption of alcohol-related memories by
mTORC1 inhibition prevents relapse (Barak et al., 2013), indicat-
ing that this pathway may be a therapeutic target for this purpose.
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FIGURE 1 | Alcohol affects local translation of proteins in amygdala of
alcohol-dependent rats. Alcohol exposure using conditioning chambers,
as well as a non-pharmacologically active alcohol injection (priming) that
served as an odor-taste cue, increased mTORC1 (mammalian target of
rapamycin complex 1) activation and the phosphorylation/activation of its
downstream substrates, such as eukaryotic translation initiation factor-4E
binding protein (4E-BP), S6 kinase (S6K) and the S6K substrates, and
increased expression of post-synaptic density-95 (PSD95) and the AMPA
receptor GluA1 subunit (Barak et al., 2013). These effects were abolished
by the mTORC1 inhibitor, rapamycin. A second pathway by which alcohol
mediates synaptic translation is by increasing extracellular glutamate. This
leads to activation of voltage-dependent Ca2+ channels (VDCCs) and
activity-dependent release of brain-derived neurotrophic factor (BDNF).
BDNF then binds and stimulates its receptor, tropomyosin-related kinase
B (TrkB), activating downstream signaling pathways, including phosphatidyl
inositol-3 kinase (PI3K), Akt and Ras, stimulating mTORC1, which
culminates in the signaling effects described above. The increased
GluA1-subunits are inserted into the membrane, increasing excitation and
alcohol-sensitive substrates. Thus, mTORC1 activation mediates the
translation of speciﬁc synaptic proteins that are important in plasticity
processes. Figure and legend were adapted from Duman and Voleti
(2012). Abbreviations: 4E-BP, 4E binding protein; eEF2K, eukaryotic
elongation factor-2 kinase; ERK, extracellular signal-regulated kinase;
MEK, MAP/ERK kinase; P indicates phosphorylated protein.
See Figure 1 for a summary of the effects of alcohol on mTORC1
and the relationship with local translation.
ALCOHOL AND BDNF
Brain derived neurotrophic factor (BDNF), another important
modulator of synaptic plasticity, regulates reward and addictive-
like behavior (Lobo et al., 2010). BDNF interacts with local
translation machinery, regulates mRNA in the dendrites, and
induces changes in synaptic and spine structure through diverse
mechanisms. Given the effects of BDNF on local transla-
tion, spine morphology and dendritic mRNA, alterations in
the BDNF system in response to alcohol and other drugs
of abuse could profoundly inﬂuence synaptic structure and
composition.
Brain derived neurotrophic factor appears to interact with alco-
hol consumption via a feedback loop that is not yet clearly deﬁned.
Endogenous BDNF negatively modulates alcohol consumption
and reward in BDNF knockout mice (Hensler et al., 2003). This
ﬁnding was corroborated in the dorsolateral striatum of wild-
type rats (Jeanblanc et al., 2009). Other studies have shown that
alcohol modulates the expression of BDNF mRNA and protein.
Schmidt et al. (2012) studied the effects of acute ethanol exposure
on alcohol/anxiety-like behaviors and the relationship to synap-
tic proteins such as BDNF and Arc. They measured changes in
expression of BDNF and Arc in the amygdala after acute expo-
sure to alcohol in alcohol-preferring (P) and non-preferring (NP)
rats. The P rats displayed innate anxiety-like behaviors and had
lower mRNA and protein levels of both BDNF and Arc in parts
of the amygdala. Acute ethanol produced an anxiolytic effect in
P, but not NP rats, and was correlated with increased mRNA and
protein levels of BDNF and Arc, suggesting that innate deﬁcits in
these proteins may be involved in the anxiety-like and excessive
alcohol-drinking behaviors of P rats. Taken together, the ﬁndings
suggest that alcohol affects BDNF/Arc expression levels and the
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BDNF system may regulate consumption and reward responses.
Figure 1 summarizes some of the effects of alcohol on BDNF and
the local translation machinery.
STIMULANTS AND LOCAL TRANSLATION
Stimulants are psychoactive substances that increase the activ-
ity of the nervous system. Cocaine and amphetamines interact
directly with the dopamine transporter, blocking dopamine reup-
take into presynaptic terminals, thus increasing the dopamine
levels in the synapse. Dopamine exerts positive effects on
the local synthesis of glutamate receptors, possibly enhancing
drug-induced reward by stimulating the ventral tegmental area
(VTA). Dopamine D1/D5 receptor activation stimulates pro-
tein synthesis in dendrites of cultured hippocampal neurons and
increases GluA1 synaptic expression (Smith et al., 2005). Minia-
ture excitatory post-synaptic currents (mEPSCs) increased in
frequency within 15 min after application of a dopamine ago-
nist, which correlated with the increased GluA1. In a second
study, this lab examined the effects of blocking the glutamater-
gic transmission of action potentials locally by blocking NMDA
receptors (NMDAR) in dendrites, while action potentials were
blocked globally with the sodium channel blocker tetrodotoxin
(Sutton et al., 2004). The loss of NMDAR signaling in dendrites
increased the expression of calcium permeable AMPA receptors
(AMPAR) at synapses, resulting in a rapid increase in mEPSC
amplitude, complementary to the increase in synaptic AMPARs.
The results suggest a homeostatic role for tonic NMDAR activ-
ity that actively controls some types of protein synthesis and
suggest that the sensitivity of the dendritic glutamatergic sys-
tem is due in large part to rapid, local changes in protein
synthesis.
Within theVTA, cocaine induces immediate changes in synapse
composition and increases excitability through an increased num-
ber of AMPARs (Bellone and Luscher, 2006). Activation of
metabotropic glutamate receptors (mGluRs) leads to long-term
depression (LTD) at many brain synapses (Malenka and Bear,
2004), and mGluR-LTD in the VTA efﬁciently reverses cocaine-
induced strengthening of excitatory inputs onto dopamine neu-
rons (Bellone and Luscher, 2006). It was later demonstrated that
the mGluR-LTD mediated reversals in cocaine-induced excitabil-
ity occur through an exchange of GluA2-lacking AMPARs for
GluA2-containing receptors (Mameli et al., 2007). Synaptic inser-
tion of GluA2 depends on rapid protein synthesis of GluA2
mRNA through the mTOR pathway (Mameli et al., 2007), the
pathway discussed above in alcohol-related memories. Overall,
the dynamic expression of glutamate receptors at post-synaptic
synapses is important for neuroadaptations following drugs of
abuse (Saba et al., 2012), and the glutamate system also plays
a key role in protein synthesis-dependent forms of synaptic
plasticity.
Cocaine regulates protein synthesis in multiple brain regions.
For example, cocaine elevates levels of BDNF in the nucleus
accumbens (NAc), a key region in the reward circuit. Grimm et al.
(2003) showed a time-dependent increase in BDNF expression
as well as increases in cocaine craving in response to a protracted
abstinence period. BDNF inhibition in the NAc decreases cocaine-
seeking (Graham et al., 2007). In contrast, BDNF injections
into the medial prefrontal cortex (mPFC) decreases cocaine
self-administration (Berglind et al., 2009), drug seeking (Sadri-
Vakili et al., 2010), and cue- and priming-induced reinstatement
(Berglind et al., 2009). BDNF injection into the NAc core, but
not the shell, causes protein synthesis- and kinase-dependent
increases in cell surface GluA1 30 min post-injection. GluA2 and
GluA3 were unaffected, suggesting an effect of BDNF on homo-
meric GluA1 calcium permeable AMPARs (Li and Wolf, 2011).
BDNF injections into the VTA and NAc also produce persistent
enhancement of cocaine-seeking (Lu et al., 2004). These results
demonstrate that exogenous BDNF rapidly increases AMPAR sur-
face expression in the rat NAc core, supporting an interaction
between increases in endogenous BDNF levels and alterations in
AMPAR transmission in cocaine-experienced rats (Li and Wolf,
2011). As discussed earlier, alcohol also affects BDNF expres-
sion levels and BDNF may regulate alcohol consumption and
reward.
Cyclic-AMP response element-binding protein (CREB) is a
candidate for mediating some of the neuroadaptations following
drugs of abuse. The role of CREB in the rewarding proper-
ties of cocaine and methamphetamines was investigated using
conditioned place preference (CPP) to measure reward memo-
ries (Kuo et al., 2007). The drugs were injected in one of three
compartments of the animal cage, and the time spent in the drug-
injected compartment was compared to the saline-injected and
drug-free compartments. If the drug is rewarding, the animal
will choose to spend longer periods of time in the drug-injected
compartment. Cocaine-induced CPP (2.5–5.0 mg/kg/dose) was
abolished by pretreatment with a protein synthesis inhibitor,
whereas methamphetamine (0.5 or 1.0 mg/kg/dose)-induced CPP
was not affected by the pretreatment. Moreover, post-treatment
with a protein synthesis inhibitor (2 h after each drug-place pair-
ing) disrupted cocaine- but not methamphetamine-induced CPP.
IncreasedCREB levels inNAcwere associatedwith cocaine, but not
methamphetamine, rewarding memories. Intra-NAc CREB anti-
sense infusion diminished cocaine- but not methamphetamine-
induced CPP. Taken together, the data show cocaine- but not
methamphetamine-associated memory formation requires de
novo protein synthesis.
The studies above highlight the various pathways through
which drugs of abuse modulate local protein synthesis. Alteration
in the glutamatergic system is an example of the dynamic changes
in synaptic receptor composition and function following drugs of
abuse. The intricate ways in which BDNF alters the effects of alco-
hol and cocaine suggest that it has region-speciﬁc roles, which rely
upon its ability to alter synaptic composition by interacting with
local protein synthesis. Furthermore, BDNF is a downstream tar-
get of different drugs in different brain regions and may represent
a common target for treating drug dependence.
LOCAL TRANSLATION AND microRNAs
microRNAs comprise a speciﬁc class of small non-coding RNAs
that bind to complementary sequences on target mRNAs to
repress translation and silence gene expression (Ambros, 2001;
Lee and Ambros, 2001). microRNAs can regulate translation of
many genes at once, making them ‘master regulators’ of cellu-
lar gene expression. They are highly abundant in the brain and
Frontiers in Molecular Neuroscience www.frontiersin.org December 2014 | Volume 7 | Article 85 | 4
Most et al. Local translation in drug addiction
play important roles in multiple biological processes, including
brain development (Krichevsky et al., 2003), synapse formation
(Schratt et al., 2006), synaptic plasticity (Smalheiser and Lugli,
2009; Cohen et al., 2011), and neuroimmune signaling (Soreq and
Wolf, 2011).
microRNAs control both translational repression and degra-
dation, and they also act in concert with RNA-binding proteins
to pinpoint their target mRNAs, which often occurs through
interaction with cis-acting elements. microRNAs are transcribed
in the nucleus as pri-microRNA. They are then cleaved by
Drosha into pre-microRNA and transported into the cytoplasmby
Exportin/RAN/GTP complex. Alternatively, they may be spliced
from introns in other genes, subjected to lariat processing, and
then folded into pre-microRNA. Dicer then completes processing
in the cytoplasm and assembly into the RNA-induced silenc-
ing complex (RISC) as dsRNA (Iwasaki et al., 2010). The RISC
complex retains the strand of microRNA with the lowest free
energy at the 5′UTR, which can bind to its target mRNAs.
microRNAs associate with Ago (Argonaute) in the RISC com-
plex to target their mRNAs (Bartel, 2009). microRNAs need
only contiguous pairing of the ‘seed’ region (nucleotides 2–7)
to successfully pair with an mRNA (Stark et al., 2005; Nielsen
et al., 2007). However, different binding patterns have been
observed that may alter the target afﬁnity of the microRNA.
Because of this, microRNAs can target and bind multiple
mRNAs, andmRNAs can havemultiplemicroRNA regulatory sites
(Goldie and Cairns, 2012).
microRNAs repress translation by blocking ribosomal interac-
tionwith the targetmRNAby preventing interaction of Eukaryotic
initiation factor (eIF4E) with mRNA or by targeting mRNAs to
P-bodies (processing bodies) for degradation (Pillai et al., 2005;
Mathonnet et al., 2007; Filipowicz et al., 2008). Degradationoccurs
when mRNAs de-circularize and ribosomes dissociate. mRNAs
then move into P-bodies where exo-nucleases can de-adenylate
and accelerate degradation (Parker and Sheth, 2007). mRNA-
microRNA interactions are reversible, allowing activity-dependent
conditions to dictate which mRNAs are targeted by the RISC
(Filipowicz et al., 2008).
microRNAs target the cis-acting elements in the 3′UTRs of
mRNAs, similar to how RNA-binding proteins operate. Several
systems portray a ‘push–pull’mechanismof inhibiting and/or pro-
moting translation in which both microRNAs and RNA-binding
proteins participate. Kv1.1, a voltage gated potassium channel, is
regulated by both HuD, an RNA-binding protein, and by miR-
129, and this occurs in response to mTOR activation (Sosanya
et al., 2013). Kv1.1 is translated in dendrites only when mTOR
activity is low (Raab-Grahamet al., 2006). BlockingmTORactivity
releasesKv1.1 frommiR-129 repression and freesHuD fromhigher
afﬁnity targets, enabling HuD to initiate translation of Kv1.1.
Moreover, NMDAR activity alters the expression levels of mul-
tiple microRNAs, including those that inhibit mTOR inhibitors
(Kye et al., 2011). In addition, miR-125 is bi-directionally reg-
ulated by mGluR activity (Muddashetty et al., 2011). miR-125a
regulates the expression of PSD-95 in response to mGluR, and the
process involves the formation of an inhibitory complex between
miR-125a and Ago2 (Muddashetty et al., 2011). These examples
demonstrate that local translational control by microRNAs is
dependent on the activity conditions and the coordinated work
of other proteins.
microRNA translational regulation may play a prominent role
in diseases such as temporal lobe epilepsy (TLE) where neu-
ronal activity is high. Silencing of miR-134 in a rat model of
epilepsy decreased the number of spontaneous seizures. The
seizure-suppressive effects implicate a neuroprotective role for
some microRNAs in the brain (Jimenez-Mateos et al., 2012). In
Parkinson’s disease, disruptions of microRNA processing involv-
ing dicer produce an up-regulation of mRNAs in dendrites of
dopaminergic neurons, and symptoms can be alleviated by rein-
troducing functional microRNAs (Gibbings et al., 2012, 2013;
Heman-Ackah et al., 2013). However, miR-125b induces cogni-
tive defects in mouse models of Alzheimer’s disease (Banzhaf-
Strathmann et al., 2014). These studies suggest that microRNAs
provide a crucial link between cellular activity and rapid, reversible
control of mRNAs in disease states (Bhattacharyya et al., 2006).
The remainder of the review will discuss the role of microR-
NAs and local mRNA targets in response to different drugs of
abuse.
microRNAs AND VALIDATED mRNA TARGETS FOLLOWING
ALCOHOL EXPOSURE
Overall, many microRNAs are up-regulated in the human alco-
holic brain (Lewohl et al., 2011). Some of these alcohol-responsive
microRNAs overlap with known local translational pathways.
The large-conductance calcium- and voltage-activated potas-
sium channel (BK) is a well-established alcohol target (Dopico
et al., 1998) and an important contributor to behavioral and
molecular alcohol tolerance (Davies et al., 2003). Alcohol up-
regulates miR-9, which targets the BK channel subunits, leading
to post-transcriptional reorganization of BK splice variants
and resulting in down-regulation of the speciﬁc splice vari-
ant that is sensitive to alcohol. This mechanism is pro-
posed to mediate development of cellular tolerance to alcohol
(Pietrzykowski et al., 2008).
A persistent up-regulation of miR-206 expression was observed
in mPFC, but not VTA, amygdala or NAc after 3 weeks of with-
drawal from a 7-week exposure to alcohol vapor (Tapocik et al.,
2013). Overexpression of miR-206 in themPFCof non-dependent
rats reproduced the escalation of alcohol self-administration seen
following a history of dependence and signiﬁcantly inhibited
BDNF expression (Tapocik et al., 2014). BDNF expression was
repressed by miR-206, but not miR-9, in a 3′UTR reporter
assay, conﬁrming BDNF as a functional target of miR-206.
Furthermore, the decreased expression was dependent on the
presence of all three miR-206 target sites in the 3′UTR of
BDNF (Tapocik et al., 2014). These results implicate miR-206
and BDNF in escalation of alcohol consumption, which is a
hallmark of alcoholism. Thus, both microRNAs and mRNAs
(discussed earlier) regulate alcohol consumption via BDNF
signaling.
Some microRNAs are down-regulated by alcohol exposure,
such as miR-382 in NAc (Li et al., 2013). MiR-382 directly tar-
gets the dopamine receptor D1 (DRD1) and can modulate the
expression of DeltaFosB. Overexpression of miR-382 attenu-
ated the alcohol-induced up-regulation of DRD1 and DeltaFosB,
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decreased voluntary alcohol intake and preference and inhibited
the DRD1-induced action potentials.
A single microRNA has the potential to target many alcohol-
responsive mRNAs (Mayﬁeld and Nunez, 2012; Tapocik et al.,
2013). This mechanism may be of particular importance in the
synaptic proteome where slight adaptations can greatly impact
synaptic plasticity. The co-expression of a microRNA with a net-
work of alcohol-responsive mRNAs supports the role of microR-
NAs as key regulators in the synapse. The biological pathways
associated with the mRNA modules include long-term potentia-
tion and depression, glutamate and neuroimmune signaling, RNA
processing, etc., supporting the role of microRNAs in multiple
processes. A subset of the mRNA changes may be driven by only a
small number of microRNAs, each with the ability to target multi-
plemRNAs, thereby greatly impacting alcohol-mediated responses
and therapeutic strategies. This process is also important formany
other diseases (Maciotta et al., 2013).
SYNAPTIC microRNA REGULATION OF mRNAs FOLLOWING
ALCOHOL CONSUMPTION
Alcohol causes extensive and coordinated changes in gene expres-
sion in the brain, suggesting common network regulators like
microRNAs may be involved. In this section, we present examples
of synapse-related microRNAs that are altered by alcohol, their
predicted targets, functional pathways, and cellular localization.
As mentioned earlier, the transcriptomes expressed in SN and
TH preparations are different, and chronic alcohol consumption
caused robust and selective changes in microRNA expression in
SN (Most et al., unpublished results), consistent with changes
seen in human alcoholics (Lewohl et al., 2011) and in other ani-
mal models of dependence (Gorini et al., 2013; Nunez et al., 2013;
Tapocik et al., 2013). Most et al. (unpublished results) proﬁled
SN and TH transcriptomes from the same samples, enabling
detection of alcohol-responsive synaptic-related microRNAs and
mRNAs and the predicted interactions between them. Predicted
microRNA-mRNA interactions identiﬁed 1,039 mRNAs and 15
microRNAs that were alcohol sensitive. Interestingly, 9 of the 15
microRNAswere previously shown tobe speciﬁc to glutamate neu-
rons, and 8 were highly predicted to target the alcohol-responsive
glutamate mRNAs. Some glutamate microRNAs (miR-203 and
miR-374) identiﬁed in SNs overlapped with human datasets
(Lewohl et al., 2011). The biological pathways associated with
the mRNA modules include long-term potentiation and depres-
sion, glutamate and neuroimmune signaling, and RNA process-
ing, suggesting regulation by microRNAs in multiple processes
(Most et al., 2014).
microRNAs that are similar in sequence, are derived from the
same premature precursor or derived from the 5′ and 3′ ends of
the same double strand, are considered to be in the same family.
miR-92a, miR-92a-1∗, miR-92a-2∗, and miR-92b are all members
of the miR-92 family (also known as the miR-17 family) and were
all up-regulated in mouse SN following chronic alcohol exposure
(Most et al., unpublished results). miR-92b is involved in synap-
tic signaling (Ceman and Saugstad, 2011) and may be involved
in the aberrant synaptic plasticity seen after alcohol exposure. In
addition, miR-369∗ is affected by alcohol. It is known to associate
directly with tumor necrosis factor α (TNF-α) mRNA to initiate
its activation under conditions of arrested growth (Vasudevan and
Steitz, 2007). This effect is dependent on the recruitment of the
RNA-binding proteins, fragile-X mental retardation-related pro-
tein 1 (FXR1) and argonaute 2 (Ago2), and can be reversed when
cells are actively proliferating, in which case miR-369∗ would then
act to represses TNF-α (Vasudevan et al., 2007). TNF-α, FXR1,
Ago2 and miR-369∗ were all altered in SNs from chronic alcohol-
treated mice (Most et al., unpublished results). Demonstration
that all of the important components of this system were changed
in SNs lends support to the utility of this preparation in studying
alcohol regulation of the transcriptome.
The SN studies also demonstrate the importance of the discrete
cellular microenvironment in identifying the effects of alcohol.
Experimental validation of the microRNA targets is needed to
determine which of the associations are of functional importance
with the potential to alter alcohol behaviors. The role of individual
microRNAs in discrete cellular compartments underscores their
essential role in cellular function and the widespread impact that
drugs of abuse can exert by targeting microRNAs.
microRNA REGULATION OF mRNAs FOLLOWING EXPOSURE
TO STIMULANTS
Stimulants such as cocaine and amphetamines increase the
levels of dopamine in the synapse in both humans and ani-
mals (Di Chiara and Imperato, 1988). miR-181a expression is
induced by exposure to dopamine, cocaine, and amphetamines
in NAc (Saba et al., 2012). miR-181a was enriched in synapses
following cocaine administration (Chandrasekar and Dreyer,
2009). Using bioinformatics tools, Chandrasekar and Dreyer
(2009) detected conserved binding sites for miR-181a within
the mRNA encoding for the GluA2 subunit of AMPARs and
subsequently showed that both overexpression and knock-
down of miR-181a regulates GluA2 translation (Figure 2).
Decreased GluA2 expression coincided with decreased spine
formation and mEPSCs. miR-181a overexpression increased
cocaine-induced CPP, while knockdown of miR-181a produced
the opposite effect (Chandrasekar and Dreyer, 2011). Taken
together, these results identify miR-181a as a key synaptic
regulator of mammalian AMPARs with the potential to reg-
ulate drug-induced synaptic plasticity (Jonkman and Kenny,
2013).
FIGURE 2 | Model for cocaine-induced microRNA-mRNA interactions.
Cocaine causes the down-regulation of let-7d, resulting in induction of its
target genes, BDNF and cAMP-responsive element-binding protein (CREB).
In contrast, miR-181a is up-regulated by cocaine, causing down-regulation
of its targets, GRM5 (glutamate metabotropic receptor 5) and AMPA
receptor subunit 2 (GluA2). These data support the involvement of let-7d
and miR-181a in regulating the differential expression of various genes in
response to cocaine, which may impact molecular adaptations leading to
addiction. Figure and legend were modiﬁed from the original in Jonkman
and Kenny (2013).
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FIGURE 3 | The interactions between miR-212, CREB, methyl
CpG-binding protein 2 (MeCP2), and BDNF. Cocaine activates
CREB-miR-212 and MeCP2-BDNF signaling and the balance between
these pathways likely regulates escalation of cocaine intake (‘loss of
control’). The orange circle illustrates CREB signaling, which protects
against the development of escalating cocaine intake, whereas the green
circle shows that MeCP2-BDNF signaling promotes escalation of intake.
Green arrows indicate a stimulatory relationship, whereas red lines
indicate an inhibitory relationship. Figure and legend were taken from
Jonkman and Kenny (2013).
Over-expression of let-7, a microRNA that is decreased
in response to cocaine, attenuated cocaine-induced CPP
(Chandrasekar and Dreyer, 2011). Let-7 targets CREB and BDNF,
and cocaine-induced decreases in let-7 increases the expression of
its targets (Chandrasekar and Dreyer, 2011).
The X-linked transcriptional repressor, methyl CpG binding
protein 2 (MeCP2), plays an important role in Rett syndrome,
a form of mental retardation, and MeCP2 translation is regu-
lated by miR-132. Blocking miR-132 activity increased MeCP2
and BDNF levels in cultured rat neurons, and the loss of MeCP2
reduced BDNF and miR-132 levels in vivo (Klein et al., 2007).
Further studies showed that MeCP2 facilitates cocaine intake
in rats with extended access to the drug and this depends on
interactions with miR-212, a family member of miR-132. The
relationship between MeCP2 and miR-212 mediates the cocaine-
induced effects on BDNF levels (Im et al., 2010; Figure 3).
Moreover, miR-212 decreases responsiveness to the motivational
properties of cocaine (Hollander et al., 2010). These ﬁndings sug-
gest a mechanism by which microRNA homeostatic control of
MeCP2 and BDNF expression affects cocaine intake and related
behaviors. The role of microRNAs (and mRNAs) in regulat-
ing the BDNF system is important in both cocaine and alcohol
action.
miR-124 and let-7d are signiﬁcantly down-regulated in the
striatum after chronic cocaine administration. Decreased BDNF
and dopamine D3 receptor mRNA and protein levels were reg-
ulated by miR-124 and let-7d, respectively (Chandrasekar and
Dreyer, 2009). Overall, brain-speciﬁc microRNA-mRNA inter-
actions are altered by drugs of abuse, suggesting that potential
pathwaysmaybe identiﬁed that are important tools for therapeutic
studies.
SUMMARY AND DISCUSSION
microRNAs are clearly involved in the neuroadaptive responses
induced by exposure to substances of abuse (e.g., alcohol
and cocaine; reviewed in Li and van der Vaart, 2011), and
their large number of targets encompasses a dynamic reg-
ulatory network. However, the processes by which microR-
NAs and mRNAs target cellular and synaptic function are
not well-understood. Because a single microRNA targets many
mRNAs, drugs of abuse can effectively hijack a complex net-
work. Indeed, the biological pathways that have been men-
tioned here are diverse and indicative of the complex dis-
ease states associated with drugs of abuse. Identiﬁcation of
the important RNA signaling systems involved in drug depen-
dence provides new areas of focus for therapeutic interven-
tions.
Future studies on translational mechanisms at localized lev-
els of the cell will reveal novel and specialized networks
that may ultimately redeﬁne treatment strategies. The SN
preparation may help pinpoint the role of synapse-related
microRNA/mRNA interactions. Local translation can be aided
by new tools to block translation of speciﬁc genes of inter-
est in speciﬁc areas such as axons (Lin and Holt, 2007), using
microﬂuidic compartmentalized cultures (Taylor et al., 2005) and
axonal application of siRNA (Hengst et al., 2006). Application
of these and other reﬁned tools will advance our apprecia-
tion of localized control of gene regulation orchestrated by
microRNA and mRNA populations. While microRNAs may be
crucial for regulating synaptic plasticity, a pivotal neuroadap-
tation in addictive behaviors, we must also understand their
role in mediating a variety of context-dependent behaviors
(Mayﬁeld and Nunez, 2012).
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ThediversemRNAs andneuroadaptations associatedwith drug
dependence may be controlled by some common microRNAs.
Also, a subset of the mRNA changes within a single disease state
may be driven by even a smaller number of microRNAs, under-
scoring the potential impact of ﬁnding those key molecules. If
microRNAs live up to their role as master regulators, then their
impact on drug-mediated responses and therapeutic strategies will
be of clinical importance.
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